Tag - VCELL

H.C. Wainwright initiated coverage of Vericel (NASDAQ:VCELL) with a “buy” rating and $19 price target. The stock closed at $13.82 on Oct. 8. Vericel, a commercial wound care company, markets two innovative tissue...